Patients with atrial fibrillation who discontinued anticoagulant treatment were at greater risk for strokes and blood clots, according to a study from researchers at Duke University and the University of California, Los Angeles. The risk was similar for those taking either warfarin or rivaroxaban. The findings will be presented during an American Heart Association webinar.
Stopping anticoagulants can harm A-fib patients, study finds
SmartBrief Job Listings for Health Care
|Senior Research Analyst||
America's Health Insurance Plans (AHIP)
|Manager, Regulatory Affairs||
|Washington DC, DC|
|Senior Counsel - FDA Regulatory Affairs||
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|